Digital chemistry is the term given to recent developments in using digital control and big data approaches for designing molecules, optimizing and controlling chemical reactions, and performing complex chemical processes under digital control with sensor feedback. A fundamental development in digital chemistry is the evolution of the concept of chemputation, which allows chemical reactions to be easily done robotically using a general purpose programming language for chemical synthesis. 

How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules

Chemify Receives Grant to Design and Discover New Drug Leads for Tuberculosis and Malaria Using Digital Chemistry Technology

Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Kevin McGowan, PhD, MBA, will join the company as Chief Business Officer (CBO). As an expert in pharmaceutical business development, platform technology strategy, sales and marketing, McGowan will help Chemify scale its commercialization and operations and further expand into U.S. markets.

Chemify hires Kevin McGowan as Chief Business Officer

Poised for an AI revolution? Drug Discovery Briefing 2024

Sifted lists Chemify as one of the drug discovery startups to watch

Rethinking Pharma and Biotech Outsourcing

Chemify's CEO highlighting the importance of data security and supply chain resilience in chemistry & drug discovery outsourcing

AI is coming. Is the chemistry world ready?

Chemify is featured in C&EN  article about AI in Chemistry

The Intersection of Chemistry, Robotics, and AI in Drug Discovery

CHEMIFY CEO INTERVIEWED by PHARMTECH.com

Chemify partners with Prepaire Labs to apply ground-breaking chemistry AI-robotics to radically accelerate the discovery of non-addictive opioids.

Chemify Partners with Prepaire Labs

Out of over 1500 screened companies, Bloomberg has selected Chemify as one of the top startups in the UK in 2023.

Chemify featured by Bloomberg as one of Top 25 UK startups to watch in 2023

Chemify founder and CEO, Lee Cronin, and an international team of researchers has developed a new theoretical framework that bridges physics and biology to provide a unified approach for understanding how complexity and evolution emerge in nature. 

CHEMIFY FOUNDER ESTABLISHES NEW "ASSEMBLY THEORY" UNIFYING PHYSICS AND BIOLOGY TO EXPLAIN EVOLUTION AND COMPLEXITY

Nominated by Alex Momeni, investor at General Catalyst, Chemify is pioneering the development of "Chemputation" the process to digitize chemistry and bridge the gap between digitally designed molecules and automated synthesis for the discovery of novel therapeutics.

Chemify featured as one of the top 11 drug discovery startups by Sifted and General Catalyst

Dewpoint Therapeutics and Chemify today announced a partnership to develop a suite of digitally discovered and automatically synthesized novel molecules on Chemify's programmable chemistry platform.

Dewpoint and Chemify announce pioneering drug discovery partnership

Chemify aims to digitise chemistry for pharma and industrial partners through a process it calls Chemputation.

Chemify, a University of Glasgow spinout, secures $43 million in Series A funding

A Scottish firm which aims to revolutionise the field of chemistry through digitisation has raised more than £33m from international investors.

Glasgow university spinout raises $43mn to ‘digitise chemistry

Chemify’s Chemputation technology allows the digital design, discovery & manufacture of complex molecules and materials.

Chemify Announces $43 Million of Funding to Digitize Chemistry

A Scottish firm which aims to revolutionise the field of chemistry through digitisation has raised more than £33m from international investors.  University of Glasgow spin-out Chemify plans to speed up the development of new drugs and medicines by automating the process of designing new molecules.

Glasgow firm Chemify raises £33m to 'digitise' chemistry

Chemify were chosen as one of the 25 winners of the venture track  competition at Falling Walls and were offered a spot to pitch.

Lee Cronin's pitch at Falling Walls Berlin

Lee Cronin is a chemist at the University of Glasgow. Listen to this podcast when Lee sits down to speak with Lex Fridman.

News&Articles